SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CNSI Cambridge Neuroscience
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
675 9 0 CNSI
Emcee:  Peter R Smith Type:  Unmoderated
Introduction Market Data Compact
I have been watching this stock since it was recommended by
a news letter and went to 12. Now the glamour has gone, is it still
a buy !!!!

They have a promising sounding drug aimed at head injuries I believe.

Can someone who has medical knowledge give their opinion on CNSI?

Peter
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
675I haven't followed cnsi, but I did notice today that McBurney is here: bg-mMike McFarland-6/21/2007
674CASH RESOURCES Net cash and short term investments as at 31 December 2005 were &Mike McFarland-7/19/2006
673CeNeS Reports 2003 Interim Results 30/09/03 cenes.comMike McFarland-9/30/2003
672CeNeS Announces Termination of its Joint Venture with Elan Cambridge, UK, 18 JuMike McFarland-6/25/2003
671CeNeS Announces Completion of Sale of Pharmaceutical Products raising a total ofnigel bates-5/22/2003
670<pre>Cambridge, UK, 16th April 2003 - CeNeS Pharmaceuticals plc (LSE: CEN)nigel bates-4/16/2003
669CeNeS Announces Phase II Drug Deal With Addex Pharmaceuticals Cambridge UK, Decnigel bates-12/19/2002
668CeNeS Announces Licensing Deal with Acorda for its Multiple Sclerosis Drug Candinigel bates-11/13/2002
667The CeNeS Pharmaceuticals Annual Report for 2001 is now available to view on theMike McFarland-7/17/2002
666CeNeS Announces Disposal of its Cognitive Testing Division Cambridge, UK, 31 Manigel bates-5/31/2002
665<i>Is The Independent generally reliable?</i> In as far as any newsnigel bates-5/21/2002
664Is The Independent generally reliable? The Indy comments on cash strapped bioteMike McFarland-5/21/2002
663CeNeS Comments on Press Speculation Regarding the Future of Company Cambridge,nigel bates-5/20/2002
662CeNeS announces further progress in its Neuropathic Pain Phase II Programme ceneMike McFarland-5/18/2002
661Message 17253954Mike McFarland-3/28/2002
660Message 17253545 preliminary year-end reportExtra Pale-3/27/2002
659I think Bioglan are pressing them for the next £1m of development funding nnigel bates-11/2/2001
658Cenes ends opiate spray deal with Bioglan LONDON, Oct 30 (Reuters) - UK healthcMike McFarland-11/2/2001
657Good website for UK biotech news: sharecast.com CPHAF has been a disaster for mMike McFarland-10/5/2001
656CeNeS reports 2001 Interim Results and Planned Restructuring Cambridge, UK Octnigel bates-10/1/2001
655yes indeed, a remarkable performance.tom pope-9/24/2001
654ww6.investorrelations.co.uk (~85p to 18p past twelve months) I need something fMike McFarland-9/24/2001
653By Jim McCamant, Editor Medical Technology Stock Letter Posted Wednesday, June smh-7/3/2001
652"sipatragine" --I found this when I spelled Sipatrigine incorrectly anMike McFarland-7/3/2001
651LONDON, June 1 (Reuters) - Healthcare firm CeNeS Pharmaceuticals Plc (LSE: CEN.Lnigel bates-6/1/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News